| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.0055 | 1 |